novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Atualização em lípidos

12 Setembro 2013

INTRODUÇÃO

João Morais
Cardiologista
Centro Hospitalar Leiria Pombal

PEDRO MARQUES DA SILVA

Pedro Marques da Silva
Hospital de Sta. Marta, CHLC, Lisboa

CARLOS AGUIAR

Carlos Aguiar
Hospital de Sta. Cruz, CHLO

DICUSSÃO

Chronic kidney disease and high blood pressure

15 Julho 2013
0

Sleep apnea. Concepts for the clinical cardiologist

14 Outubro 2013
0

-->